|
|
Article: Chiron Will Not Supply BEGRIVAC(TM) Influenza Virus Vaccine to Non-U.S. Markets for the 2005-2006 Influenza Season; Company is Working to Cover BEGRIVAC Vaccine Shortfall with Other Non-U.S. Influenza Vaccines.
- Article from:
- Business Wire
- Article date:
- July 20, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
EMERYVILLE, Calif. -- No Change to Financial Guidance
Chiron Corporation (NASDAQ:CHIR) today announced that further testing has confirmed the company will not be able to supply any BEGRIVAC(TM) influenza virus vaccine doses to non-U.S. markets during the 2005-2006 influenza season. There are no other changes from the company's previous announcement on July 15, 2005, on the same subject.
About Chiron
Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in ...